In regards to customer receipts, that makes sense, thanks for the heads up.
The $300k I believe was over the lifetime of both products, “along with sales of Cresos animal health product, anibidiol, following the launch of that product” and was on the ann released 27/2 so includes up to this date not just Q4 2017. I’m still confused as to when CannaQIX was actually launched which seems to have contributed to the majority of revenue, do you know?
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report & Appendix 4C
In regards to customer receipts, that makes sense, thanks for...
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online